LARA BARCO: Open Payments
NPI 1528738689 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 40 payments from 11 companies in 2025. Trend: 2023 $524 · 2024 $1,295 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $277 |
| Novo Nordisk Inc | 11 | $199 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Verona Pharma, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Corium, LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: QULIPTA, Ozempic, UBRELVY, VRAYLAR, TRELEGY ELLIPTA, Wegovy, JARDIANCE, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
